INTRODUCTION AND HYPOTHESIS: The purpose of our study was to estimate the frequency and risk factors for symptomatic urinary tract infection (UTI) after surgery for stress urinary incontinence (SUI) and/or pelvic organ prolapse (POP). METHODS: Case-control study of 389 consecutive women who underwent surgery for POP and/or SUI. Cases were defined as a symptomatic, culture-confirmed UTI within 6 weeks of surgery. Multivariable logistic regression was used to determine independent risk factors. RESULTS: Thirty five (9%) women developed a UTI. The risk of UTI was significantly increased by previous history of multiple UTIs (adjusted OR: 3.7, CI 1.4-10.1), increased distance between the urethra and the anus (adjusted OR: 1.4, CI 1.1-1.9), and prolonged duration of catheterization (adjusted odds ratio (OR) for >or=10 days: 4.2, 95% CI 1.5-11.6); 94.6% of catheterizing women were prescribed daily nitrofurantoin. CONCLUSIONS: UTI is an important postoperative morbidity after urogynecologic surgery and is common in catheterizing women despite antibiotic prophylaxis.
INTRODUCTION AND HYPOTHESIS: The purpose of our study was to estimate the frequency and risk factors for symptomatic urinary tract infection (UTI) after surgery for stress urinary incontinence (SUI) and/or pelvic organ prolapse (POP). METHODS: Case-control study of 389 consecutive women who underwent surgery for POP and/or SUI. Cases were defined as a symptomatic, culture-confirmed UTI within 6 weeks of surgery. Multivariable logistic regression was used to determine independent risk factors. RESULTS: Thirty five (9%) women developed a UTI. The risk of UTI was significantly increased by previous history of multiple UTIs (adjusted OR: 3.7, CI 1.4-10.1), increased distance between the urethra and the anus (adjusted OR: 1.4, CI 1.1-1.9), and prolonged duration of catheterization (adjusted odds ratio (OR) for >or=10 days: 4.2, 95% CI 1.5-11.6); 94.6% of catheterizing women were prescribed daily nitrofurantoin. CONCLUSIONS: UTI is an important postoperative morbidity after urogynecologic surgery and is common in catheterizing women despite antibiotic prophylaxis.
Authors: Christopher P Chung; Thomas J Kuehl; Sheena K Harris; Madeline M McBride; Wilma I Larsen; Paul M Yandell; Bobby L Shull Journal: Int Urogynecol J Date: 2012-03-08 Impact factor: 2.894
Authors: Ruchira Singh; Erik D Hokenstad; Sheila R Wiest; Shunaha Kim-Fine; Amy L Weaver; Michaela E McGree; Christopher J Klingele; Emanuel C Trabuco; John B Gebhart Journal: Int Urogynecol J Date: 2018-08-25 Impact factor: 2.894
Authors: AeuMuro Gashaw Lake; Alexandra M McPencow; Madeline A Dick-Biascoechea; Deanna K Martin; Elisabeth A Erekson Journal: Am J Obstet Gynecol Date: 2013-06-13 Impact factor: 8.661
Authors: Margaret G Mueller; Dana Elborno; Bhumy A Davé; Alix Leader-Cramer; Christina Lewicky-Gaupp; Kimberly Kenton Journal: Int Urogynecol J Date: 2016-06-16 Impact factor: 2.894